Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2007
11/07/2007CN101066260A Coenzyme Q10 emulsion and its freeze dried prepn and their prepn process
11/07/2007CN101066259A Solid dispersion of higher fatty alcohol and its prepn
11/07/2007CN101066258A Inclusion compound of higher fatty alcohol and its prepn
11/07/2007CN101066254A Slow releasing ranolazine micro pill
11/07/2007CN101066253A Slow releasing ranolazine tablet
11/07/2007CN101066244A Small volume vincamine injection and its prepn process
11/07/2007CN101066083A Health tea of aizoon stonecrop herb
11/07/2007CN100347306C Method and means for producing protein with prospective post-translation modification
11/07/2007CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/07/2007CN100347186C Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/07/2007CN100347174C Heterocyclic hepyramine derivative, its preparation and use thereof
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346801C Substance for treating celebral ischemia extracted from haw
11/07/2007CN100346798C Traditional Chinese medicine active part composition for curing cardio and cerebral vascular disease and its preparing method
11/07/2007CN100346797C Compound injection from ice tablet and ginkgo leaf extract and its making method thereof
11/07/2007CN100346792C Benzothiazole derivatives as adenosine receptor ligands
11/07/2007CN100346776C Remedies
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291738 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291636 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291623 Compounds that interact with kinases
11/06/2007US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291604 Administering to tissue, such as blood vessel and active nucleic acids ; insertion of stents; cardiovascular disorders
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/06/2007CA2182795C Superactive vip antagonists
11/06/2007CA2113089C Universal donor cells
11/01/2007WO2007124447A2 Use of chalcogenides for treating shock and other adverse conditions
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007123984A2 Pre-mixed, ready-to-use pharmaceutical compositions
11/01/2007WO2007123718A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES
11/01/2007WO2007123233A1 Gene associated with arteriosclerotic disease, and use thereof
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123126A1 Agent for improving decreased exercise tolerance in chronic heart failure
11/01/2007WO2007122970A1 Ligand capable of binding to nuclear receptor
11/01/2007WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007WO2007122466A1 Pyridine[3,4-b]pyrazinones
11/01/2007WO2007122382A2 Lycopene for the treatment of metabolic dysfunction
11/01/2007WO2007122280A1 Use of the liver growth factor (lgf) as pleiotropic tissue regenerator
11/01/2007WO2007121923A1 Purine derivatives as a2a receptor agonists
11/01/2007WO2007121921A2 Purine derivatives for use as adenosin a2a receptor agonists
11/01/2007WO2007121588A1 Treatment of atrial fibrillation
11/01/2007WO2007121584A1 Food product containing policosanols
11/01/2007WO2007121495A2 Method for diagnosing cardiovascular diseases
11/01/2007WO2007092379A3 Sesamol derivatives as novel inhibitors of arachidonic acid formation
11/01/2007WO2007072147A3 Composition for diagnosing and treating circulatory system diseases
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2007017436A3 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts
11/01/2007WO2003105886A3 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070254956 Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation
11/01/2007US20070254945 Aminocyclohexyl ether compounds and uses thereof
11/01/2007US20070254943 pulmonary disorders; bronchodilators; 2-[(S)-1-{2-[4-(2-Ethylaminoethyl)phenyl]ethyl}pyrrolidin-3-yl]-2,2-diphenylacetamide
11/01/2007US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
11/01/2007US20070254931 Thiazole Derivatives Having Vap-1 Inhibitory Activity
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254908 7-azaindoles, pharmaceutical compositions and their therapeutic applications
11/01/2007US20070254903 Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
11/01/2007US20070254902 Methods and compositions utilizing quinazolinones
11/01/2007US20070254900 Treatments for Congestive Heart Failure
11/01/2007US20070254894 Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254861 Methods for the prevention and/or treatment of peripheral arterial disease
11/01/2007US20070254849 Ryanodine receptor inhibitors and methods relating thereto
11/01/2007US20070254847 Pharmaceutical Composition Containing Steroidal Saponins, the Preparation Method and Use Thereof
11/01/2007US20070254839 Orally administered peptides synergize statin activity
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
11/01/2007US20070254031 Rapidly disintegrable solid preparation
11/01/2007US20070254022 Cationic liposome delivery of taxanes to angiogenic blood vessels
11/01/2007US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007CA2650922A1 Pre-mixed, ready-to-use nicardipine compositions
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2648813A1 Organic compounds
11/01/2007CA2648741A1 Purine derivatives as a2a receptor agonists
11/01/2007CA2647677A1 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646674A1 Use of chalcogenides for treating shock and other adverse conditions
10/2007
10/31/2007EP1849795A1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
10/31/2007EP1849774A1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
10/31/2007EP1848699A1 Anthranilic acid derivatives as hm74a receptor agonists
10/31/2007EP1848445A1 Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 1595